nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion
|
van Riel, J.M. |
|
2009 |
45 |
14 |
p. 2519-2527 9 p. |
artikel |
2 |
Calendar
|
|
|
2009 |
45 |
14 |
p. I- 1 p. |
artikel |
3 |
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
|
Mandalà, M. |
|
2009 |
45 |
14 |
p. 2537-2545 9 p. |
artikel |
4 |
Current perspective: Bevacizumab in colorectal cancer – A time for reappraisal?
|
Okines, Alicia |
|
2009 |
45 |
14 |
p. 2452-2461 10 p. |
artikel |
5 |
CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival
|
Mirisola, Valentina |
|
2009 |
45 |
14 |
p. 2579-2587 9 p. |
artikel |
6 |
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology
|
Maschmeyer, Georg |
|
2009 |
45 |
14 |
p. 2462-2472 11 p. |
artikel |
7 |
Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
|
Macefield, Rhiannon C. |
|
2009 |
45 |
14 |
p. 2569-2573 5 p. |
artikel |
8 |
Editorial board
|
|
|
2009 |
45 |
14 |
p. ii- 1 p. |
artikel |
9 |
EJC NEWS, ISSUE 14, 2009
|
|
|
2009 |
45 |
14 |
p. 2439-2443 5 p. |
artikel |
10 |
Estimation of an optimal chemotherapy utilisation rate for colon cancer: An evidence-based benchmark for cancer care
|
Jacob, Susannah |
|
2009 |
45 |
14 |
p. 2503-2509 7 p. |
artikel |
11 |
Ethidium bromide as a vital probe of mitochondrial DNA in carcinoma cells
|
Villa, Anna Maria |
|
2009 |
45 |
14 |
p. 2588-2597 10 p. |
artikel |
12 |
FASLG polymorphism is associated with cancer risk
|
Liu, Yan |
|
2009 |
45 |
14 |
p. 2574-2578 5 p. |
artikel |
13 |
Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
|
Gabellini, Chiara |
|
2009 |
45 |
14 |
p. 2618-2627 10 p. |
artikel |
14 |
Health and persistent functional late effects in adult survivors of childhood CNS tumours: A population-based cohort study
|
Boman, K.K. |
|
2009 |
45 |
14 |
p. 2552-2561 10 p. |
artikel |
15 |
In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma
|
Pellizzari Tregno, Francesca |
|
2009 |
45 |
14 |
p. 2606-2617 12 p. |
artikel |
16 |
Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n =647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study
|
Willemoe, Gro L. |
|
2009 |
45 |
14 |
p. 2528-2536 9 p. |
artikel |
17 |
Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma
|
Hundsdoerfer, Patrick |
|
2009 |
45 |
14 |
p. 2447-2451 5 p. |
artikel |
18 |
Meta-analysis of genetic polymorphisms and gastric cancer risk: Variability in associations according to race
|
Loh, Marie |
|
2009 |
45 |
14 |
p. 2562-2568 7 p. |
artikel |
19 |
Patients’ and health care professionals’ evaluation of health-related quality of life issues in bone metastases
|
Harris, Kristin |
|
2009 |
45 |
14 |
p. 2510-2518 9 p. |
artikel |
20 |
Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)
|
Magnusson, Marie |
|
2009 |
45 |
14 |
p. 2488-2495 8 p. |
artikel |
21 |
Radiation-induced thyroid changes: A retrospective and a prospective view
|
Massimino, Maura |
|
2009 |
45 |
14 |
p. 2546-2551 6 p. |
artikel |
22 |
Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial
|
Alkner, Sara |
|
2009 |
45 |
14 |
p. 2496-2502 7 p. |
artikel |
23 |
Targeted therapies in the treatment of advanced/metastatic NSCLC
|
Pallis, A.G. |
|
2009 |
45 |
14 |
p. 2473-2487 15 p. |
artikel |
24 |
Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer
|
Schmitt, Manfred |
|
2009 |
45 |
14 |
p. 2444-2446 3 p. |
artikel |
25 |
TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis
|
Chen, Bo |
|
2009 |
45 |
14 |
p. 2598-2605 8 p. |
artikel |